{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 4α,5α-Epoxy-3,17β-dihydroxy-4β,17α-dimethylandrost-2-ene-2-carbonitrile
| image = Epostane.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 80471-63-2
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 6917713
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 5292942
| UNII = 6375T36951
| KEGG = 
| ChEBI = 
| ChEMBL = 2106218

<!--Chemical data-->
| C=22 | H=31 | N=1 | O=3
| molecular_weight = 357.494 g/mol
| SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@]45[C@@]3(CC(=C([C@]4(O5)C)O)C#N)C
| StdInChI_Ref = 
| StdInChI = 1S/C22H31NO3/c1-18-8-6-16-14(15(18)7-9-20(18,3)25)5-10-22-19(16,2)11-13(12-23)17(24)21(22,4)26-22/h14-16,24-25H,5-11H2,1-4H3/t14-,15-,16-,18-,19+,20-,21+,22-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = CETKWEWBSMKADK-GSXVSZIWSA-N
| synonyms = WIN-32729
}}

'''Epostane''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]], [[British Approved Name|BAN]]) (developmental code name '''WIN-32729''') is an [[enzyme inhibitor|inhibitor]] of [[3β-hydroxysteroid dehydrogenase]] (3β-HSD) that was developed as an [[contraceptive]], [[abortifacient]], and [[oxytocic]] [[drug]] but was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA492|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=492–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA113|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=113–}}</ref> By inhibiting 3β-HSD, epostane blocks the [[biosynthesis]] of [[progesterone]] from [[pregnenolone]] (and also the conversion of [[dehydroepiandrosterone]] to [[androstenedione]]), thereby functioning as an [[antiprogestogen]] and terminating [[pregnancy]].<ref name="Elks2014" /> The drug was trialed and in a study was found to be slightly more effective at inducing [[medical abortion|abortion]] relative to [[mifepristone]].<ref name="Lachelin2013">{{cite book|author=Gillian C. L. Lachelin|title=Introduction to Clinical Reproductive Endocrinology|url=https://books.google.com/books?id=RaHpAgAAQBAJ&pg=PA198|date=11 September 2013|publisher=Elsevier Science|isbn=978-1-4831-9380-9|pages=198–}}</ref>
<!--
==Synthesis==
[[File:Epostane synthesis.png|thumb|center|500px|Epostane synthesis: [[Sterling Drug]], R. G. Christiansen, {{Cite patent|DE|2855091}} (1979).]]-->

==See also==
* [[Nisterime]]
* [[Trilostane]]

==References==
{{Reflist|2}}


[[Category:3β-Hydroxysteroid dehydrogenase inhibitors]]
[[Category:Androstanes]]
[[Category:Antiprogestogens]]
[[Category:Nitriles]]
[[Category:Epoxides]]


{{steroid-stub}}